(hyaluronate sodium)

HYALOVET has been trusted by veterinarians for more than 20 years to provide a predictable clinical response for treatment of joint dysfunction.

HYALOVET is manufactured for optimum purity using molecular filtration technology that removes extraneous fractions and impurities.

HYALOVET provides dosing flexibility with 2 mL vial and 2 mL syringe presentations.

  • 2 mL filled syringe (20 mg / 2 mL)
  • 12 X 2 mL filled syringes (20 mg / 2 mL)
  • 2 mL vial (20 mg / 2 mL)
  • 24 X 2 mL vials (20 mg / 2 mL)

Not for human use. HYALOVET Injection must not be administered intravascularly. As with any intra-articular injection, a mild inflammatory response may be seen in the joint following HYALOVET injection. The response is self-limiting but may last from 2 to 5 days after treatment. If inflammation is excessive or severe, the possibility of infection should be considered and appropriate antibiotic therapy instituted.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • Molecular filtration technology removes extraneous fractions and impurities
  • FDA approved hyaluronic acid
  • No refrigeration required, stores at room temperature
  • The recommended dose of HYALOVET (hyaluronate sodium) is 2 mL (20 mg hyaluronate sodium) in small or medium sized joints (carpus, fetlock) given by intra-articular injection. More than one joint may be treated at the same time. If necessary, the injection may be repeated after one or more weeks, but not to exceed 2 injections per week for a total of 4 weeks.
  • HYALOVET should be injected using strict aseptic technique. Excess synovial fluid should be removed prior to injection.
  • For best results horses should be given two days of rest or limited exercise before resuming normal training.

Product Resources

Technical Assistance

  • Boehringer Ingelheim Vetmedica, Inc.

    Equine Division

    3902 Gene Field Road
    St. Joseph, Missouri 64506

    • Phone 866-638-2226
    • Fax 816-676-4326